Macrophage migration inhibitory factor contributes to hypoxic pulmonary vasoconstriction in rats

Area of Science:

• Pulmonary Hypertension Research
• Vascular Biology
• Inflammation and Immunity

Background:

• Chronic hypoxia can cause pulmonary hypertension, with inflammation playing a key role in pulmonary artery dysfunction.
• Macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine, is upregulated in the pulmonary arteries of rats with hypoxic pulmonary hypertension.

Purpose of the Study:

• To investigate the role of Macrophage migration inhibitory factor (MIF) in modulating the vasoreactivity of isolated pulmonary artery rings.
• To elucidate the mechanisms by which MIF influences pulmonary artery constriction.

Main Methods:

• Established hypoxic pulmonary hypertension models in Sprague-Dawley rats through chronic intermittent hypoxia exposure.
• Utilized immunohistochemistry and Western blot to assess MIF expression in pulmonary arteries.
• Measured isometric force in isolated intrapulmonary artery rings to evaluate vasoreactivity.

Main Results:

• MIF mediates enhanced pulmonary arterial vasoconstriction following chronic hypoxia and contributes to delayed hypoxic constriction.
• MIF potentiates phenylephrine-induced vasoconstriction concentration-dependently, an effect independent of the endothelium.
• MIF-induced potentiation is partially inhibited by PKC, p38, and ERK1/2 pathway inhibitors.

Conclusions:

• MIF enhances agonist-induced pulmonary artery vasoconstriction via PKC, p38, and ERK1/2 signaling pathways.
• These findings suggest MIF plays a significant role in hypoxic pulmonary vasoconstriction and the development of pulmonary hypertension.